Article Text


AB0119 Primary sjogren’s syndrome associated with anterior horn cell disorder
  1. JC Tseng,
  2. HH Cheng,
  3. RJ Hu,
  4. LY Lu
  1. Allergy, Immunology and Rheumatology, Veterans General Hospital, Kaohsiung, Taiwan, R.O.C


Background Central nervous system (CNS) involvement in primary Sjogren’s syndrome (pSS) is controversial with regard to incidence, aetiology and pathogenesis. In the literature, the incidence of CNS-SS varies widely, ranging from rare to incidence rates of 20% to 25%. The clinical picture is diverse, ranging from mild cognitive symptoms to fatal cerebrovascular accidents.

Objectives We describe a patient with pSS presenting with dysphagia and progressive respiratory failure resulting from anterior horn cell disorder. To the best of our knowledge this is the first case reported in medical literature. The disease responded to corticosteroids and hydroxychloroquine treatment.

Methods A 58-year-old woman had a one year history of dry eyes and dry mouth. She experienced progressive dysphagia and dyspnea ten days prior to admission. She developed progressive respiratory muscle weakness which resulted in respiratory failure and received mechanical ventilation during admission. Examination revealed symmetrically decreased muscle power without sensory impairment and positive Schirmer test. Blood investigations revealed positive ANA, anti-SS-A and elevated IgG level up to 2820 mg/dl. Full blood cell count and creatine kinase level were normal. Sjogren’s syndrome was confirmed by minor salivary gland biopsy. Electromyography, nerve conduction velocity and evoked potential studies showed anterior horn cell disorder. MRI of brain revealed negative finding. The disease improved with administration of corticosteroids and hydroxychloroquine.

Conclusion Sjoren’s syndrome should be considered in the differential diagnosis of patients with motor neuron diseases. Promop diagnosis and treatment are required to prevent further morbidity and mortality.


  1. Cox PD, Hales RE. CNS Sjogren’s syndrome: an underrecognized and underappreciated neuropsychiatric disorder. J Neuropsychiatry Clin Neurosci. 1999;11(2):241–7

  2. Wright RA, O’Duffy JD, Rodriguez M. Improvement of myelopathy in Sjogren’s syndrome with chlorambucil and prednisolone therapy. Neurology 1999;52(2):386–8

  3. Ioannidis JP, Moutsopoulos HM. Sjogren’s syndrome: too many associations, too limited evidence. The enigmatic example of CNS involvement. Semin Arthritis Rheum. 1999;29(1):1–3

  4. Niemela RK, Hakala M. Primary Sjogren’s syndrome with severe central nervous system disease. Semin Arthritis Rheum. 1999;29(1):4-13

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.